Baxter International, Deerfield, Ill., announced plans to acquire Baxa Corp., a manufacturer of equipment that automates oral and IV dose preparation and delivery.
Baxter to buy Baxa Corp. for $380 million
Baxter will pay $380 million to buy the privately held Englewood, Colo.-based company, which has operations also in Florida and the U.K., according to a Baxter news release. The acquisition is subject to antitrust review by the Federal Trade Commission.
Both companies specialize in equipment that standardizes medication and nutrition doses in hospitals as a way to reduce errors.
Baxa had annual sales of about $150 million in 2010. Publicly traded Baxter said it expects the acquisition to dilute 2012 earnings by 3 cents to 5 cents per share through transaction-related costs and then become accretive to company earnings thereafter.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.